Tirzepatide

Tirzepatide (Mounjaro, Zepbound) is a groundbreaking "dual agonist" peptide used for Type 2 diabetes management and chronic weight loss. It is the first medication in a class known as "twincretins" because it mimics two different metabolic hormones at once. 

Dual-Action Mechanism

Tirzepatide mimics two naturally occurring incretin hormones that help regulate blood sugar and appetite: 

• GLP-1 (Glucagon-like Peptide-1): Slows stomach emptying and signals the brain to feel full.

• GIP (Glucose-dependent Insulinotropic Polypeptide): Enhances insulin secretion and is thought to improve fat metabolism and energy balance.

• Synergy: By activating both pathways, Tirzepatide generally produces more significant weight loss than medications that target GLP-1 alone, such as Semaglutide like Ozempic or Wegovy